AMA raises concern about pharmacists providing antiviral therapy.
In President Joe Biden’s State of the Union address, he announced the launch of a Test and Treat Initiative, where consumers testing positive for COVID-19 at certain pharmacies will be given antiviral therapy by an on-site provider on the spot and at no cost.
However, there’s already a debate about who should be able to prescribe these antiviral pills as the U.S. Department of Health and Human Services (HHS) began distributing them in the last few weeks.
The American Medical Association (AMA) expressed concern about the initiative allowing a provider without an established patient-doctor relationship with the consumer to prescribe the pills. In other words, the AMA is uncomfortable with pharmacists or anyone else without an ongoing and well-established medical relationship with the patient prescribing anything under the initiative. According to the AMA, one of the antivirals to be prescribed has over six pages of drug interactions that would require patients to modify or even stop other prescriptions they are taking. The organization stated that prescribing these without full patient history and ongoing monitoring sets a very dangerous precedent because while these pharmacy-based clinics are equipped to treat simple conditions, COVID-19 and the antiviral medications that treat it are too complicated for this on-site service.
On the flip side, pharmacists believe they should be able to prescribe the antivirals if the initiative hopes to meet its stated goal of providing the most vulnerable and underserved Americans with access to lifesaving treatment. Pharmacists believe that expanding the power to prescribe these pills beyond just on-site providers would not only expand access to the initiative but also would be an obvious and safe choice considering pharmacists’ extensive knowledge of medication and side effects.
When asked about the reach of the initiative, pharmacists say that not only should the program be expanded to include a lot more pharmacies nationwide, but that the best way to do that would be to allow them to prescribe the antiviral pills. However, currently the Test and Treat initiative limits participating pharmacies to just those with onsite clinics with a provider.
These types of pharmacies are far less likely to be found in rural and sparsely populated areas. For example, CVS Minute Clinics, which would be eligible to prescribe antivirals under the initiative, make up only 10 percent of all CVS Pharmacies. By limiting the ability to prescribe the antiviral pills to these pharmacies with on-site providers, thousands of other pharmacies across America are ineligible to participate, many in areas that serve some of the hardest hit populations and populations without insurance.
Additionally, pharmacists also believe they would be the perfect prescribers of the antiviral pills. In fact, they say they have already been prescribing some COVID treatments since last year under other federal statutes. Pharmacists also have extensive knowledge about medication, of course, and understand potential interactions and side effects. When asked about the issue, one professor of pharmacy even called pharmacists “medication experts”.
After the AMA issued a statement about their concerns, the Biden administration encouraged people who do have a regular health care provider to continue seeing that provider for testing or when they’ve received a positive COVID-19 test at a treatment site. This appears to have pacified the AMA and other physicians’ worries for the time being. However, there is still a very real concern for Americans without insurance and without access to a primary care physician.
As antiviral pills have begun arriving at pharmacies that signed up for the initiative, a federal website to search and find locations has yet to fully launch but is expected by months end.
With COVID-19 cases falling, increased vaccine and testing availability, and now increased treatment options, Americans are rapidly moving towards a new normal as we hit the two-year anniversary of COVID-19 lockdowns.
Readers last week surely noted my coverage of a few of the key regulatory initiatives the Biden Administration intends to undertake during the last part
Well, the debate was held between Vice President Kamala Harris and former President Donald Trump, and healthcare, particularly the Affordable Care Act (ACA), emerged as
Please log in to your account to comment on this article.
Join Beth Wolf, MD, CPC, CCDS, for an in-depth webcast on the FY2025 spinal fusion MS-DRG updates. Discover key changes in DRG classification, understand impacts on documentation and CMI, and learn strategies to ensure compliance.
Join Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, as she presents effective strategies to strengthen collaboration between CDI, coding, and quality departments in acute care hospitals. Angela will also share guidance on implementing cross-departmental meetings, using shared KPIs, and engaging leadership to foster a culture of collaboration. Attendees will gain actionable tools to optimize documentation accuracy, elevate quality metrics, and drive a unified approach to healthcare goals, ultimately enhancing both patient outcomes and organizational performance.
Optimize your outpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to outpatient CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. You will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.
Enhancing outpatient clinical documentation is crucial for maintaining accuracy, compliance, and proper reimbursement in today’s complex healthcare environment. This webcast, presented by industry expert Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, will provide you with actionable strategies to tackle complex challenges in outpatient documentation. You’ll learn how to craft detailed clinical narratives, utilize advanced EHR features, and implement accurate risk adjustment and HCC coding. The session also covers essential regulatory updates to keep your documentation practices compliant. Join us to gain the tools you need to improve documentation quality, support better patient care, and ensure financial integrity.
Dr. Ronald Hirsch provides critical details on the new Medicare Appeal Process for Status Changes for patients whose status changes during their hospital stay. He also delves into other scenarios of hospital patients receiving custodial care or medically unnecessary services where patient notifications may be needed along with the processes necessary to ensure compliance with state and federal guidance.
Healthcare organizations face complex regulatory requirements under the No Surprises Act and Price Transparency rules. These policies mandate extensive fee disclosures across settings, and confusion is widespread—many hospitals remain unaware they must post every contracted rate. Non-compliance could lead to costly penalties, financial loss, and legal risks. Join David M. Glaser Esq. as he shows you how to navigate these regulations effectively.
Protect your facility from unwanted audits! Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, and take a deep dive into both the CMS and AMA guidelines for reporting post operative pain blocks. You’ll learn how to determine if the nerve block is separately codable with real life examples for better understanding. Becky will also cover how to evaluate whether documentation supports medical necessity, offer recommendations for stronger documentation practices, and provide guidance on educating providers about documentation requirements. She’ll include a discussion of appropriate modifier and diagnosis coding assignment so that you can be confident that your billing of post operative pain blocks is fully supported and compliant.
During this RACmonitor webcast Dr. Ronald Hirsch spotlights the areas of the OIG’s Work Plan and the findings of their most recent audits that impact utilization review, case management, and audit staff. He also provides his common-sense interpretation of the prevailing regulations related to those target issues. You’ll walk away better equipped with strategies to put in place immediately to reduce your risk of paybacks, increased scrutiny, and criminal penalties.
Copyright © 2024 RACmonitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24Â
